LungLife AI
Company Profile
Company website
Sector
Medical Equipment and Services (Medical Equipment)
Description
LungLife is a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence. The Company’s core technologies are integrated in the LungLB® test, which is intended to be used as a tool to provide physicians with additional information to help in the decision-making process for people with indeterminate lung nodules that may be lung cancer following a CT scan.
Investor Access
05
Jun
Event information
Management will hold the company’s AGM at 4:00 P.M. (BST) on 5 June 2024.
Please check here for more information: https://www.londonstockexchange.com/news-article/LLAI/publication-of-annual-report-and-notice-of-agm/16439562Venue
at Investec Bank plc, 30 Gresham Street, London, EC2V 7QP
Time
Wednesday 5 June 2024 at 4pm BST
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | September |
| Interim Results* | March |
| AGM* | May |
* Months based on previous announcements of this kind
